Idiopathic Chylothorax: Is it a Benign or Malignant Diagnosis? by Naffouj, Sandra & Omar, Jasmine-Yasmine
Henry Ford Health System
Henry Ford Health System Scholarly Commons
Case Reports Medical Education Research Forum 2019
5-2019
Idiopathic Chylothorax: Is it a Benign or Malignant
Diagnosis?
Sandra Naffouj
Henry Ford Health System
Jasmine-Yasmine Omar
Henry Ford Health System
Follow this and additional works at: https://scholarlycommons.henryford.com/merf2019caserpt
This Poster is brought to you for free and open access by the Medical Education Research Forum 2019 at Henry Ford Health System Scholarly
Commons. It has been accepted for inclusion in Case Reports by an authorized administrator of Henry Ford Health System Scholarly Commons. For
more information, please contact acabrer4@hfhs.org.
Recommended Citation
Naffouj, Sandra and Omar, Jasmine-Yasmine, "Idiopathic Chylothorax: Is it a Benign or Malignant Diagnosis?" (2019). Case Reports.
60.
https://scholarlycommons.henryford.com/merf2019caserpt/60
Background
Case Presentation
Idiopathic Chylothorax; is it a benign or malignant diagnosis?
Sandra Naffouj, MD; Jasmine Omar, MD
Henry Ford Health System / Wayne State University
Detroit, Michigan 
• Chylothorax is the presence of chyle in the pleural space 
with a triglyceride (TG) level >110 mg/dl or evidence of 
chylomicrons in the pleural fluid.
• The main etiologies for chylothorax are traumatic (thoracic 
surgery) and non-traumatic (malignancy). 
Discussion
• 29-year-old healthy male presenting with acute onset of 
dyspnea and right-sided pleuritic chest pain. 
• CT chest showed large right-sided pleural effusion. 
Thoracentesis was performed, draining 2 liters of turbid 
white pleural fluid; a chest tube was placed. 
• Pleural fluid analysis: exudative effusion with lymphocytic 
predominance and TG of 1,100 mg/dl. Cytology and 
cultures negative for malignancy and infection.
• Patient was made NPO; TPN and IV Octreotide were 
started. Lymphangiogram showed chyle leak from the 
thoracic duct (TD) at the level of T7-T8. He underwent  
embolization, however high-volume chyle leakage was 
persistent. 
• Patient underwent video assisted thoracoscopy (VATs) and 
TD ligation. Output downtrend, pleural effusion resolved, 
and chest tube was removed. Diet was advanced to low-fat, 
medium chain triglyceride (MCT) diet. 
• No leak recurrence at 1-month follow-up.
• An evaluation of the most common causes of non-traumatic 
chylothorax include:
 Malignancy (lymphomas, lung and mediastinal cancers)
 Infections (tuberculosis, fungal infections)
 Congenital disorders of the lymphatic system
• Conservative management includes:
 Nothing by mouth or a low-fat diet with MCTs
 TPN to replace protein and electrolytes, and deliver lipids 
directly into the bloodstream, thereby bypassing the 
lymphatic system and decreasing chyle flow. 
 Octreotide is an adjunct to help reduce chyle absorption 
from the intestines. 
• Possible interventional modalities include:
 TD embolization 
 TD ligation
 Pleurodesis
• A combination of conservative and operative interventions was 
performed in our case given high-output of chyle and absence 
of a clear etiology.
• It is crucial to perform a comprehensive assessment in non-
traumatic chylothorax to exclude occult underlying etiology.
Case Presentation
• Pleural biopsy was negative for malignancy. Serum LDH, AFP, 
B-hCG, HIV, AFB, fungal, and anaerobic cultures were all 
negative. Peripheral blood smear was negative for dysplasia and 
blasts. Full body CT did not show any evidence of malignancy. 
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